WATSON 803 (Meclizine 25 mg)
Pill imprint WATSON 803 has been identified as Meclizine hydrochloride 25 mg.
Meclizine is used in the treatment of vertigo; nausea/vomiting; motion sickness and belongs to the drug class anticholinergic antiemetics. There is no proven risk in humans during pregnancy. Meclizine 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WATSON 803
- Strength:
- 25 mg
- Color:
- White & Yellow
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- Anticholinergic antiemetics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0803
- Inactive Ingredients:
- silicon dioxide colloidal
corn starch
D&C Yellow No. 10 Lake
lactose monohydrate
microcrystalline cellulose
sodium starch glycolate
stearic acid
More about meclizine
Consumer resources
- Other brands: Antivert, Bonine, Dramamine Less Drowsy, Travel Sickness, More (5) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
